Medication info
Neokan-D Tablet 4mg (Candesartan Cilexetil)

Neokan-D Tablet 4mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›4mg / 1 tablet
Manufacturer / importer
Green Cross Corporation
Appearance
White to grayish-white, round, biconvex tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202500590 · Approved 2025.03.17 · Insurance code 643606840

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medication at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with close caution. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension: The safety and efficacy have not been established in adolescents and children aged 18 years or younger. 2. Heart failure: The safety and efficacy have not been established in adolescents and children aged 18 years or younger.

Ingredients

Manufacturer
Green Cross Corporation

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular contraction function
  • reduced left ventricular ejection fraction
View approved original text

This medication helps to control the blood pressure of patients with essential hypertension. Additionally, it is used as an adjunct treatment in heart failure patients with impaired left ventricular contraction function who do not achieve adequate effects from ACE inhibitors alone or do not tolerate them well. It contributes to reducing the burden on the heart and improving heart failure symptoms. Therefore, it is effectively used in the treatment of essential hypertension and specific heart failure patients.

How to take

Adult dose

Take this medication at the same time each day, with or without food. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with close caution. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, up to a maximum of 32 mg once daily, taking the patient's tolerability into account. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension: The safety and efficacy have not been established in adolescents and children aged 18 years or younger. 2. Heart failure: The safety and efficacy have not been established in adolescents and children aged 18 years or younger.

Precautions

This medication can cause serious harm to the fetus and newborns, especially during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. Patients with a known allergy to this medication, pregnant or nursing women, patients with severe liver dysfunction or bile duct obstruction, and patients with hereditary angioedema should not use it. Additionally, patients with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should also not take this medication. Elderly patients, those with hyperkalemia, liver disease, valvular heart disease, ischemic heart disease, or cerebrovascular disorders should use this medication with caution. Side effects such as dizziness, back pain, and respiratory infections may occur, and in heart failure patients, hypotension, hyperkalemia, and renal dysfunction may also be observed, so caution is required. Regular monitoring of serum potassium and creatinine levels is important to assess kidney function and electrolyte status. When used with other antihypertensive agents, the blood pressure-lowering effect may be enhanced, so dose adjustments and patient monitoring are necessary. Particularly when taken in conjunction with potassium-sparing diuretics or potassium supplements, serum potassium levels may rise to dangerous levels, thus requiring caution. Use during pregnancy poses risks to the fetus, and women of childbearing age or those who are pregnant should consult a physician. Nursing women should preferably avoid this medication, and if it is necessary to use it, breastfeeding should be discontinued. The safety and effectiveness of this medication in children and adolescents under 18 years of age have not been established. Elderly patients are at risk of excessive blood pressure lowering leading to cerebral infarction; therefore, they should exercise caution when using this medication. In cases of overdose, hypotension, dizziness, and tachycardia may occur, necessitating immediate medical attention, and this medication is not removed through dialysis. This medication should be kept out of the reach of children, and transferring it to other containers should be avoided to maintain quality.

Side effects

  • dizziness
  • lower back pain
  • respiratory infection
  • upper respiratory tract infection
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • sensory disturbance
  • dyspepsia
Show 61 more
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal impairment
  • increased creatinine
  • increased urea
  • increased potassium
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • headache
  • intestinal vascular edema
  • nausea
  • diarrhea
  • elevated liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated gamma-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • arthralgia
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from air and moisture exposure. It is important to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature, which helps ensure the longevity of the medication's efficacy.

Appearance and packaging

Appearance

White to grayish-white, round, biconvex tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.